Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
Common Stock
Vivos Therapeutics Inc
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Common Stock
$180
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-81%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Common Stock
$90k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Common Stock
$2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
CVS Health Corp
NYSE:CVS
|
Common Stock
$49.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
122%
|
|
Cigna Corp
NYSE:CI
|
Common Stock
$4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-27%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Common Stock
$7.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-3%
|
See Also
What is Vivos Therapeutics Inc's Common Stock?
Common Stock
180
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Common Stock amounts to 180 USD.
What is Vivos Therapeutics Inc's Common Stock growth rate?
Common Stock CAGR 5Y
-81%